Herbas VPB

Print
EN | LT
LT - Anti-CTLA-4 antikūnų kompozicijos
EN - ANTI-CTLA-4 ANTIBODY COMPOSITIONS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395 (2006.01)
A61K 47/18 (2006.01)
A61P 35/00 (2006.01)
C07K 16/28 (2006.01)
European patent
(11) Number of the document 1865986
(13) Kind of document T
(96) European patent application number 06736812.6
Date of filing the European patent application 2006-03-02
(97) Date of publication of the European application 2007-12-19
(45) Date of publication and mention of the grant of the patent 2016-02-17
(46) Date of publication of the claims translation 2016-06-10
PCT application
(86) Number PCT/US2006/007555
Date 2006-03-02
PCT application publication
(87) Number WO 2006/096491
Date 2006-09-14
Priority applications
(30) Number Date Country code
659766 P 2005-03-08 US
728165 P 2005-10-19 US
752712 P 2005-12-20 US
762456 P 2006-01-26 US
Inventors
(72)
ABATE, Justin Donald, US
DAS, Tapan Kanti, US
ELLIOTT, Carrie Marie, US
MUTHURANIA, Kevin Wamiti, US
NEMA, Sandeep, US
SINGH, Satish Kumar, US
Grantee
(73) Pfizer Products Inc., Eastern Point Road, Groton, CT 06340, US
Attorney or representative
(74) Tatjana STERLINA, UAB "Intels", Naugarduko g. 32/2, LT-03225 Vilnius, LT
Title
(54) Anti-CTLA-4 antikūnų kompozicijos
  ANTI-CTLA-4 ANTIBODY COMPOSITIONS
Last renewal fee
Payment date Validity (years) Amount
2017-02-27 12 289.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2018-03-02